Serioangiographic study of protective action of cyproterone acetate against renal vasospasm following testosterone plus vasopressin administration in rats.
D000792:Angiography / Q000379:methods*; D000818:Animals; D003534:Cyproterone / Q000031:analogs & derivatives* / Q000494:pharmacology; D017373:Cyproterone Acetate; D008297:Male; D051381:Rats; D012077:Renal Artery / Q000000981:diagnostic imaging; D012079:Renal Circulation / Q000187:drug effects*; D013739:Testosterone / Q000031:analogs & derivatives* / Q000494:pharmacology; D043343:Testosterone Propionate / Q000031:analogs & derivatives; D014661:Vasoconstriction / Q000187:drug effects*; D014667:Vasopressins / Q000008:administration & dosage / Q000494:pharmacology*
D014667:Vasopressins; D013739:Testosterone; D017373:Cyproterone Acetate; C035458:testosterone 17-phenylpropionate; D003534:Cyproterone; D043343:Testosterone Propionate